Shikiar Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $214K | Hold |
|
|||||
|
2025
Q2 | $147K | Hold |
|
|||||
|
2025
Q1 | $119K | Hold |
|
|||||
|
2024
Q4 | $114K | Hold |
|
|||||
|
2024
Q3 | $137K | Hold |
|
|||||
|
2024
Q2 | $180K | Sell |
|
|||||
|
2024
Q1 | $499K | Hold |
|
|||||
|
2023
Q4 | $499K | Hold |
|
|||||
|
2023
Q3 | $466K | Hold |
|
|||||
|
2023
Q2 | $344K | Hold |
|
|||||
|
2023
Q1 | $307K | Buy |
|
|||||
|
2022
Q3 | $277K | Hold |
|
|||||
|
2022
Q2 | $272K | Hold |
|
|||||
|
2022
Q1 | $290K | Sell |
|
|||||
|
2021
Q4 | $317K | Hold |
|
|||||
|
2021
Q3 | $561K | Sell |
|
|||||
|
2021
Q2 | $815K | Buy |
|
|||||
|
2021
Q1 | $689K | Sell |
|
|||||
|
2020
Q4 | $720K | Sell |
|
|||||
|
2020
Q3 | $859K | Sell |
|
|||||
|
2020
Q2 | $1.34M | Sell |
|
|||||
|
2020
Q1 | $937K | Sell |
|
|||||
|
2019
Q4 | $2.24M | Buy |
|
|||||
|
2019
Q3 | $1.58M | Buy |
|
|||||
|
2019
Q2 | $2.32M | Sell |
|
|||||
|
2019
Q1 | $2.97M | Buy |
|
|||||
|
2018
Q4 | $3.21M | Sell |
|
|||||
|
2018
Q3 | $3.7M | Buy |
|
|||||
|
2018
Q2 | $2.4M | Buy |
|
|||||
|
2018
Q1 | $2.27M | Buy |
|
|||||
|
2017
Q4 | $782K | Sell |
|
|||||
|
2017
Q3 | $665K | Buy |
|